Stifel Financial’s Alder Biopharmaceuticals ALDR Stock Holding History

Stifel Financial’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-12,153	Closed	-$229K	–	3153
2019 Q3	$229K	Sell	12,153 -60,562	-83%	-$693K	﹤0.01%	2586
2019 Q2	$856K	Sell	72,715 -24,730	-25%	-$299K	﹤0.01%	1897
2019 Q1	$1.33M	Buy	97,445 +82,332	+545%	+$1.07M	﹤0.01%	1483
2018 Q4	$154K	Buy	+15,113	New	+$193K	﹤0.01%	2507
2017 Q2	–	Sell	-9,920	Closed	-$206K	–	2659
2017 Q1	$206K	Buy	+9,920	New	+$220K	﹤0.01%	2310
2016 Q4	–	Sell	-7,122	Closed	-$234K	–	2594
2016 Q3	$234K	Buy	+7,122	New	+$217K	﹤0.01%	2104
2015 Q4	–	Sell	-17,100	Closed	-$691K	–	2425
2015 Q3	$691K	Buy	+17,100	New	+$727K	﹤0.01%	1383

Stifel Financial's ALDR Position: Q4 2019 in Review

Stifel Financial sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 12,153 shares — an estimated $229K sold.

Stifel Financial first reported a position in ALDR in Q3 2015 and held it in 7 quarters. The position peaked at $1.33M in Q1 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Stifel Financial reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Stifel Financial sold 12,153 Alder Biopharmaceuticals shares in Q4 2019, an estimated $229K.
Stifel Financial first reported a position in Alder Biopharmaceuticals in Q3 2015 and held it in 7 quarters.
Stifel Financial's Alder Biopharmaceuticals position peaked at $1.33M in Q1 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Stifel Financial's 13F filing for Q4 2019, filed 13 Feb 2020.